Explore how leading healthcare organizations are moving beyond reimbursement rates to build payer strategies grounded in operational readiness, physician alignment, and sustainable growth.
At a Glance
- Payer Strategy Is an Enterprise Issue
Payer decisions now affect operations, physician alignment, patient access, revenue, and organizational independence—not just reimbursement rates. - Operational Readiness Matters More Than Contract Terms
A favorable contract can lose value quickly if prior authorizations, reporting requirements, and administrative burdens exceed the organization's ability to execute. - Negotiate Around Capabilities, Not Assumptions
The strongest payer agreements align with what the organization can reliably measure, manage, and deliver at scale. - Risk-Based Care Requires Real Infrastructure
Success in value-based models depends on strong data, care management, physician engagement, and governance—not just willingness to accept risk. - Denials Are Strategic Intelligence
Denial trends reveal breakdowns in workflows, documentation, contracts, and payer relationships, providing valuable insight for improvement and negotiation. - Physician Alignment Is Essential
Payer strategies work best when physicians help shape them. Trust, transparency, and shared governance are critical to long-term success. - Direct-to-Employer Contracting Creates New Leverage
Employer partnerships can diversify revenue, strengthen market position, and provide an alternative path to traditional payer relationships. - Build an Integrated Payer Strategy Operating Model
High-performing organizations align contracting, revenue cycle, analytics, clinical leadership, and value-based care efforts around a single payer portfolio strategy.
There was a time when reimbursement strategy could sit comfortably outside the center of enterprise planning. Contracting negotiated the agreements. Revenue cycle managed what slipped through the cracks. Executives focused on growth, capital planning, physician recruitment, and market position.
That era has passed.
Today, payer strategy reaches into nearly every corner of a healthcare organization. Benefit design, prior authorization rules, utilization management, risk transfer, network design, and data requirements now shape not only reimbursement, but also operational capacity, physician alignment, patient access, and strategic independence. Payer strategy is no longer a branch of revenue cycle. It is an enterprise discipline.
At BHS Connect, our work with leading healthcare organizations has given us a close view of how these pressures show up in real operating environments. The pattern is familiar: administrative friction increases, payer oversight expands, and organizations are pushed toward financial risk before the infrastructure beneath that risk is fully mature. What may appear at first to be a contracting issue often reveals something larger: a fragmented internal approach that allows payers to define the terms of engagement.
Drawing from our Release of Information partnerships and the strategies we have seen work in practice, the BHS team developed this article to help healthcare leaders bring greater coherence, discipline, and intentionality to payer strategy. The goal is not simply to secure better rates. The larger opportunity is to build the capabilities that allow an organization to decide which payer positions to advance, how much risk to accept, and how to negotiate from a place of clarity rather than strain.
For healthcare executives, the implication is clear: when payer margins compress, pressure often moves outward.
The New Payer Power Equation
Payers are under visible pressure, and they are responding with force. Recent analysis from McKinsey describes a gathering storm in which both payers and health systems face intensifying margin pressure. Federal budget constraints, rising utilization, specialty drug spending, and regulatory shifts are tightening the financial vise across the healthcare ecosystem.
For healthcare executives, the implication is clear: when payer margins compress, pressure often moves outward. Unit costs are challenged. Utilization controls tighten. Administrative requirements expand. Risk is pushed further onto providers.
Inside healthcare organizations, this rarely arrives as one dramatic blow. It accumulates more quietly, like grit in the gears. A contract with reasonable base rates includes prior authorization rules that care teams cannot operationalize efficiently. A new quality incentive program is layered onto an already crowded metrics environment. A risk-based product reaches the market before the organization has built care management at scale, turning the first performance year into an expensive learning curve.
Many organizations continue to negotiate as though rates are the primary lever and internal capabilities will eventually catch up. Yet the balance of power has shifted. Payers increasingly arrive at the table with sophisticated analytics on cost drivers, site-of-care patterns, referral behavior, leakage, and provider variation. They use those insights to design requirements and narrow networks with precision.
If provider organizations cannot meet that sophistication with their own data, their own operational truth, and a grounded view of what they can reliably execute, even a strong rate increase becomes fragile. The C-suite’s role is to ensure that payer conversations begin not with a wish list of economic terms, but with a clear-eyed assessment of operational muscle.
From Rate-Centric Negotiation to Capability-Centric Strategy
The burden of payer requirements is no longer anecdotal. The American Medical Association’s survey on prior authorization shows that more than nine in ten physicians believe these rules harm patient outcomes and delay access to care. Nearly a quarter report that prior authorization has contributed to serious adverse events.
This is not only a clinical concern. It is a structural business issue. Every added layer of authorization, documentation, step therapy, appeal, or payer-specific workflow widens the gap between the contracted rate and the dollars that actually arrive.
Still, many negotiations remain centered on the fee schedule as though it were the whole story. Finance seeks rate relief to offset rising labor and supply costs. Physicians push for fewer administrative barriers. Contracting teams look for a workable compromise. Operational leaders are often pulled in only after terms are nearly complete.
The result is predictable. The organization wins a headline rate increase, but the contract carries utilization controls, documentation requirements, and appeal processes that the current infrastructure cannot support without eroding margin, morale, or both.
A capability-centric approach changes the sequence. It treats the true value of a contract as the negotiated rate minus the cost of execution. That cost includes compliance burden, authorization friction, denial rework, documentation load, technology gaps, and clinical disruption.
This approach begins with practical internal questions:
Which metrics can we reliably measure and improve across service lines? Where do we have clinical leadership strong enough to support pathway-driven agreements? Which documentation and authorization processes can our technology and staffing sustain at scale? Where are we ready to accept performance accountability, and where would doing so outpace our current capabilities?
In negotiation, those answers become both boundaries and leverage. The organization can push hard where it knows it can perform and resist terms that would quietly drain margin or clinician trust.
Consider a cardiovascular service line with standardized pathways, registry participation, strong physician leadership, and disciplined outcomes tracking. In that environment, the organization can negotiate not only for improved reimbursement, but also for streamlined prior authorization, auto-approval criteria tied to pathway adherence, and quality incentives that reflect demonstrated performance.
In a service line where documentation remains inconsistent and clinical pathways are still maturing, a more measured arrangement may create more long-term value. Stability, data improvement, and operational readiness may matter more than an aggressive performance guarantee.
The message for the C-suite is simple: payer agreements are strongest when they are built around what the organization can reliably execute, not merely what it hopes to achieve.
Direct-to-employer contracting can create cleaner data flows, more focused population strategies, and room to test care models that are difficult to launch across multiple commercial payer relationships.
Direct-to-Employer Contracting as a Strategic Counterweight
Direct-to-employer contracting appears in many strategic plans, but in many organizations it never advances beyond a pilot. The hesitation is understandable. These arrangements sit outside the traditional comfort zone of provider organizations. They require actuarial insight, benefit design collaboration, service guarantees, data-sharing discipline, and a sales rhythm that feels different from payer negotiation.
At the same time, employers are actively searching for alternatives (such as near site and virtual experiences). Many want closer relationships with local delivery systems that can help manage cost, quality, access, and employee experience. Their interest is growing as healthcare spending consumes more attention in benefit strategy.
That curiosity creates leverage, but only for organizations prepared to treat direct-to-employer contracting as part of the payer portfolio rather than a side experiment.
For the C-suite, the opportunity is not limited to incremental volume. These contracts can create cleaner data flows, more focused population strategies, and room to test care models that are difficult to launch across multiple commercial payer relationships. A regional employer partnership around musculoskeletal care, for example, could include access guarantees, digital triage, conservative therapy as the first step, standardized surgical pathways, and transparent reporting.
If the model works, it becomes more than a one-off arrangement. It becomes a proof point. It informs commercial payer negotiations, sharpens internal investment priorities, and gives the organization a real-world laboratory for digital tools, care management, and specialty alignment.
The barrier is often governance. Direct-to-employer work may live inside a small business development function with limited connection to contracting, revenue cycle, clinical leadership, analytics, or IT. That separation turns a promising strategy into an isolated project.
The C-suite can change that by pulling employer partnerships into the broader payer strategy conversation, setting clear objectives, and confirming that commitments around service levels, data reporting, access, and risk sharing are operationally feasible.
When structured thoughtfully, direct-to-employer contracting becomes a strategic counterweight. It diversifies the payer portfolio, strengthens market relationships, and gives the organization another path to shape its future rather than merely react to payer movement.
Risk-Based Models: Readiness Matters More Than Vocabulary
Most healthcare executives are fluent in the language of value-based care. Shared savings, downside risk, population health, quality incentives, attribution, and total cost of care are now part of the standard strategic vocabulary.
The harder question is whether the organization is truly prepared to carry meaningful downside risk.
Policy direction continues to move toward accountability. The Health Care Payment Learning & Action Network Alternative Payment Model Framework lays out a progression from traditional fee-for-service to population-based risk. MedPAC’s work on Accountable Care Organization Payment Systems reinforces a similar trajectory, showing how Medicare Shared Savings Program models have evolved through structures that increase both the potential for reward and the exposure to loss.
These signals matter. They invite leaders to look beyond contract design and examine operational readiness.
Risk readiness is rarely a legal or financial issue alone. At its core, it is operational. Organizations that enter upside-only arrangements without building the capabilities beneath them often find themselves cornered when payers push toward two-sided risk. The spreadsheet may look encouraging. The lived reality may tell another story.
Patient attribution feels unreliable. Data arrive too late or in formats clinicians cannot use. Care management exists more as a strategic aspiration than a scaled operating engine. Physicians question whether performance metrics reflect clinical reality. Analytics teams spend more time reconciling data than guiding decisions.
A realistic standard for risk readiness begins with attribution. Physicians need confidence that the patients assigned to them reflect how care is actually delivered. Without that foundation, every downstream intervention rests on uncertain ground.
Timely, credible data are equally essential. Total cost and utilization patterns need to connect to the moments where clinical decisions are made. Information cannot remain locked behind dashboards that require translation before action. It has to reach clinical leaders in a form they trust and can use.
Operational capacity is the next pillar. Care coordination, patient outreach, and engagement efforts need to function at scale. A small pilot may prove the concept, but it will not bend the cost curve across a risk-bearing population. Governance completes the picture. Physician-led structures must be able to define pathways, address unwarranted variation, and align incentives in ways clinicians see as fair, practical, and grounded.
When these elements are weak, downside risk turns aspiration into exposure. Imagine an organization that accepts downside risk for complex chronic patients without a stable care coordination engine. Avoidable admissions do not fall. Out-of-network leakage continues. The organization absorbs a significant loss.
The financial result is painful. The deeper cost is cultural. Physicians walk away saying, “We tried that, and it did not work.” That sentence can echo for years.
For the C-suite, the work is to require a structured, cross-functional assessment before entering or expanding downside arrangements. Finance, clinical leadership, care management, analytics, IT, contracting, and revenue cycle each see a different part of the terrain. Together, they can determine whether the organization is ready to move, where it needs to build, and which opportunities are better declined until the foundation is stronger.
In value-based care, restraint can be strategic. Saying no to a contract that exceeds current capability may preserve the credibility needed to say yes later.
Denials as a Strategic Feedback System
Denials are often treated as an unpleasant but predictable feature of revenue cycle. They sit in back-office work queues, generate periodic escalations, and become urgent when a payer pattern becomes especially disruptive.
Viewed only this way, denials remain a financial clean-up problem. Viewed differently, they become one of the clearest feedback systems an organization has.
Denial patterns reveal where payer requirements collide with internal performance. They show where documentation does not support medical necessity, where authorization workflows break down, where front-end processes are vulnerable, and where payer policies create friction that contracts fail to address.
The environment is becoming more difficult. Industry analysis has pointed to rising initial denial rates and growing aged accounts receivable, particularly in Medicare Advantage and commercial lines of business. Many healthcare organizations feel this shift every day: more claims require rework, appeal, escalation, or write-off.
The strategic shift is to treat denials not only as dollars at risk, but as signals from the operating system.
When denial analytics are segmented by payer, denial category, service line, site of care, provider, and root cause, patterns come into focus. A cluster of medical necessity denials around a high-revenue procedure may reveal a disconnect between payer criteria and the way severity is documented in the EHR. A surge in technical denials tied to eligibility or authorization may point to gaps in scheduling, preregistration, or insurance verification. A concentration of denials in one payer relationship may become evidence for contract clarification, escalation, or renegotiation.
At a minimum, executive dashboards benefit from showing:
- Denial rates and dollars by payer, denial category, and major service line
- The proportion of denials that are preventable through internal process improvement versus those driven primarily by payer policy
When denial data are framed this way, the conversation changes. Instead of asking revenue cycle leaders why denial rates are high, executives can bring the right cross-functional teams together to address structural causes.
Contracting can use denial trends to negotiate clearer criteria or better data feeds. Clinical leaders can work with documentation and coding teams to close gaps. IT can refine order sets and workflow design. Revenue cycle can shift from recovery to prevention.
Over time, denials become less of a back-office burden and more of an enterprise intelligence system. They show leaders where the contract, the payer, the clinician, the workflow, and the data are out of alignment.
The C-suite opportunity is to make payer strategy something physicians help shape, not something they simply absorb.
Aligning Physicians Without Eroding Trust
Physicians are not peripheral to payer strategy. They are central to it.
Yet many physicians experience payer-related initiatives as a steady accumulation of burden: more documentation, more pathway rules, more prior authorization steps, more dashboards, more metrics. Without careful framing, each new requirement can feel like an external force pressing against professional judgment.
Surveys of physicians participating in value-based arrangements reflect this tension. Athenahealth’s Embracing Value-Based Care: Insights for Physicians and Staff notes that physicians often recognize the potential of value-based care to influence cost and quality, while also reporting strain from data demands, workflow disruption, and incentive models that do not always reflect clinical reality.
The C-suite opportunity is to make payer strategy something physicians help shape, not something they simply absorb.
Transparency is the starting point. When executives share payer-specific data showing where requirements are clinically unreasonable, where practice variation creates financial exposure, and where patients encounter friction, physicians can see themselves in the story. They are no longer being handed a mandate. They are being invited into a shared problem.
Consider an analysis of colorectal surgery showing that a small group of surgeons has higher post-acute costs and readmission rates under a bundled model. Presented as a cost problem, the information will likely create defensiveness. Presented as a joint inquiry—grounded in evidence, connected to patient outcomes, and supported by credible data—it can become the beginning of surgeon-led pathway redesign.
Governance matters just as much. Major payer decisions involving quality metrics, care model changes, risk sharing, or performance incentives require physician leaders at the decision-making table. Advisory input is not the same as shared ownership. When physicians participate in setting the terms of risk, selecting measures, and determining how incentives will be allocated, they are more likely to engage in the work of changing practice patterns.
The reverse is also true. When payer strategy arrives as a series of centrally created mandates, resistance is predictable. The organization’s ability to meet contractual commitments becomes fragile because the people closest to care delivery do not trust the architecture around them.
Trust is not a soft variable in payer strategy. It is load-bearing.
A strong operating model changes the character of executive work.
Building an Integrated Payer Strategy Operating Model
Most healthcare organizations already have the essential pieces of payer strategy distributed across the enterprise. Contracting manages agreements and renewals. Revenue cycle works denials and collections. A value-based care team pilots ACOs or bundled payments. Business development explores employer partnerships. Clinical leadership drives quality initiatives that may or may not connect directly to payer expectations. IT and analytics support each function in different ways.
Each team may be doing meaningful work. Yet without an integrating framework, the result can become a patchwork of contracts, pilots, dashboards, and improvement efforts that never quite form a true portfolio. The organization is active, but not always aligned. Like musicians playing from different sheets of music, the talent is present, but the performance lacks a single score.
Payers often approach this work differently. McKinsey’s 2024 Payers Outlook: Opportunities Abound describes how payer executives are navigating cost pressure, growth opportunities, product strategy, and the expanding role of data, analytics, and generative AI. One can debate the merits of individual payer tactics, but the coordination behind them is unmistakable. Product design, network strategy, utilization management, analytics, technology investment, and risk models are increasingly connected to a larger strategic plan.
Provider organizations need the same level of coherence.
In practice, this often means creating a cross-functional payer strategy council that includes contracting, finance, revenue cycle, clinical leadership, IT, analytics, care management, and leaders responsible for employer and value-based work. This group defines the target payer portfolio, establishes criteria for opportunities worth pursuing, and monitors performance across the enterprise.
Within this model, analytics becomes a shared asset rather than a departmental tool. Payer scorecards can combine financial performance, denial trends, risk model results, operational friction, access issues, physician feedback, and relationship indicators. As negotiations approach, those scorecards help determine whether to expand, stabilize, renegotiate, or reduce a payer relationship. When new opportunities emerge, whether direct-to-employer partnerships, risk-based contracts, or novel quality arrangements, the same readiness criteria apply. The organization gains discipline. Decisions become less episodic and more intentional.
A strong operating model changes the character of executive work. Contracting, risk, and employer strategies are no longer evaluated in separate lanes; they are considered against one explicit payer portfolio vision. Investments in care management, data, physician leadership, and workflow design are no longer justified one initiative at a time; they are tied to the capabilities the organization needs in order to perform under that vision.
This level of coordination does not remove uncertainty. Healthcare will always contain uncertainty. But it prevents payer-related decisions from becoming ad hoc. It gives the organization a compass instead of a collection of maps, helping leaders move with greater confidence through a market where the terrain is shifting under everyone’s feet.
Final Thoughts
Many elements of payer strategy can be delegated. Frontline managers can refine workflows. Revenue cycle teams can strengthen appeals. Contracting specialists can manage day-to-day payer interactions. Clinical leaders can guide care model improvement.
What cannot be delegated is the executive work of defining the payer portfolio the organization intends to build, the level of risk it is prepared to carry, and the capabilities required to support that posture over time.
For the C-suite, payer strategy belongs at the center of enterprise planning. Every significant payer conversation benefits from beginning with a candid assessment of capability, not simply a financial pro forma. Direct-to-employer opportunities, risk-based contracts, denial trends, physician alignment, and data infrastructure are not separate conversations. They are connected parts of one strategic system.
BHS partners with leading healthcare organizations to provide a full range of no-cost Release of Information (ROI) services supporting Medical Records and Health Information Management teams.
If someone on your team would like to explore how we can support your facility, please feel free to reach out. We’d be happy to share more details and answer any questions.
